Skip to main content
  • 438 Accesses

Résumé

Les auto-anticorps (AAC), aussi nommés anticorps naturels, sont des anticorps présents dans la circulation d’individus sains, et qui sont produits en l’absence d’une stimulation antigénique spécifique [1]. Découverts à la fin des années 1980 par le groupe d’Avrameas [2, 3], les AAC correspondent aux immunoglobulines (Ig).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Coutinho A (1995) Immune or autoimmune? Clin Exp Immunol 101 Suppl 1: 3–5

    Article  PubMed Central  PubMed  Google Scholar 

  2. Dighiero G, Lymberi P, Guilbert B, et al. (1986) Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann N Y Acad Sci 475: 135–45

    Article  PubMed  CAS  Google Scholar 

  3. Avrameas S (1991) Natural autoantibodies: from ”horror autotoxicus“ to ”gnothi seauton“. Immunol Today 12: 154–9

    PubMed  CAS  Google Scholar 

  4. Berneman A, Ternynck T, Avrameas S (1992) Natural mouse IgG reacts with self antigens including molecules involved in the immune response. Eur J Immunol 22: 625–33

    Article  PubMed  CAS  Google Scholar 

  5. Grandien A, Coutinho A, Andersson J, et al. (1991) Endogenous VH gene family expression in immunoglobulin-transgenic mice: evidence for selection of antibody repertoires. Int Immunol 3: 67–73

    Article  PubMed  CAS  Google Scholar 

  6. Avrameas S, Ternynck T (1993) The natural autoantibodies system: between hypotheses and facts. Mol Immunol 30: 1133–42

    Article  PubMed  CAS  Google Scholar 

  7. Zelenay S, Moraes Fontes MF, Fesel C, et al. (2007) Physiopathology of natural auto-antibodies: the case for regulation. J Autoimmun 29: 229–35

    Article  PubMed  CAS  Google Scholar 

  8. Coutinho A, Kazatchkine MD, Avrameas S (1995) Natural autoantibodies. Curr Opin Immunol 7: 812–8

    Article  PubMed  CAS  Google Scholar 

  9. Adib M, Ragimbeau J, Avrameas S, et al. (1990) IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol 145: 3807–13

    PubMed  CAS  Google Scholar 

  10. Shlomchik MJ, Aucoin AH, Pisetsky DS, et al. (1987) Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA 84: 9150–4

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  11. Coutinho A, Avrameas S (1992) Speculations on immunosomatics: potential diagnostic and therapeutic value of immune homeostasis concepts. Scand J Immunol 36: 527–32

    Article  PubMed  CAS  Google Scholar 

  12. Ando K, Kikugawa K, Beppu M (1994) Involvement of sialylated poly-N-acetyllactosaminyl sugar chains of band 3 glycoprotein on senescent erythrocytes in anti-band 3 autoantibody binding. J Biol Chem 269: 19394–8

    PubMed  CAS  Google Scholar 

  13. Schlesinger LS, Horwitz MA (1994) A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect Immun 62: 280–9

    PubMed Central  PubMed  CAS  Google Scholar 

  14. Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, et al. (1987) The role of clonal selection and somatic mutation in autoimmunity. Nature 328: 805–11

    Article  PubMed  CAS  Google Scholar 

  15. Bendtzen K, Hansen MB, Ross C, et al. (1996) Cytokine autoantibodies. In: J. B. Peter and Y. Shoenfeld (ed) Autoantibodies, Amsterdam, p 260–16

    Google Scholar 

  16. Antonelli G (1997) In vivo development of antibody to interferons: an update to 1996. J Interferon Cytokine Res 17 Suppl 1: S39–46

    PubMed  CAS  Google Scholar 

  17. Jouvenne P, Fossiez F, Banchereau J, et al. (1997) High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: a follow-up study. Scand J Immunol 46: 413–8

    Article  PubMed  CAS  Google Scholar 

  18. Rapoport SI (1976) Blood-Brain Barrier in Physiology and Medicine. Raven Press, New York

    Google Scholar 

  19. Ritchie TC, Fabian RH, Choate JV, et al. (1986) Axonal transport of monoclonal antibodies. J Neurosci 6: 1177–84

    PubMed  CAS  Google Scholar 

  20. Ritchie TC, Fabian RH, Coulter JD (1985) Axonal transport of antibodies to subcellular and protein fractions of rat brain. Brain Res 343: 252–61

    Article  PubMed  CAS  Google Scholar 

  21. Adamson P, Wilbourn B, Etienne-Manneville S, et al. (2002) Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling. FASEB J 16: 1185–94

    Article  PubMed  CAS  Google Scholar 

  22. Klein R, Bansch M, Berg PA (1992) Clinical relevance of antibodies against serotonin and gangliosides in patients with primary fibromyalgia syndrome. Psychoneuroendocrinology 17: 593–8

    Article  PubMed  CAS  Google Scholar 

  23. Tanaka S, Matsunaga H, Kimura M, et al. (2003) Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol 141: 155–64

    Article  PubMed  CAS  Google Scholar 

  24. Schott K, Schaefer JE, Richartz E, et al. (2003) Autoantibodies to serotonin in serum of patients with psychiatric disorders. Psychiatry Res 121: 51–7

    Article  PubMed  CAS  Google Scholar 

  25. Fetissov SO, Hallman J, Oreland L, et al. (2002) Autoantibodies against alfa-MSH, ACTH and LHRH in anorexia and bulimia nervosa patients. Proc Nat Acad Sci 99: 17155–60

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  26. Fetissov SO, Harro J, Jaanisk M, et al. (2005) Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci USA 102: 14865–70

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  27. Sinno MH, Do Rego JC, Coeffier M, et al. (2009) Regulation of feeding and anxiety by alpha-MSH reactive autoantibodies. Psychoneuroendocrinology 34: 140–9

    Article  PubMed  CAS  Google Scholar 

  28. Fetissov SO, Dechelotte P (2008) The putative role of neuropeptide autoantibodies in anorexia nervosa. Curr Opin Clin Nutr Metab Care 11: 428–34

    Article  PubMed  CAS  Google Scholar 

  29. Fetissov SO, Hamze Sinno M, Coeffier M, et al. (2008) Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 24: 348–59

    Article  PubMed  CAS  Google Scholar 

  30. Fetissov SO, Hamze Sinno M, Coquerel Q, et al. (2008) Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition 24: 854–9

    Article  PubMed  CAS  Google Scholar 

  31. Blazer DG (2000) Mood disorders: epidemiology. In: B. J. Sadock and V. A. Sadock (ed) Comprehensive Textbook of Psychiatry, New York, p 1298–308

    Google Scholar 

  32. Zorrilla EP, Luborsky L, McKay JR, et al. (2001) The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 15: 199–226

    Article  PubMed  CAS  Google Scholar 

  33. Dunn AJ, Swiergiel AH, de Beaurepaire R (2005) Cytokines as mediators of depression: what can we learn from animal studies? Neurosci Biobehav Rev 29: 891–909

    Article  PubMed  CAS  Google Scholar 

  34. Schleifer SJ, Keller SE, Bond RN, et al. (1989) Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry 46: 81–7

    Article  PubMed  CAS  Google Scholar 

  35. Anisman H, Ravindran AV, Griffiths J, et al. (1999) Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biol Psychiatry 46: 1649–55

    Article  PubMed  CAS  Google Scholar 

  36. Roy BF, Rose JW, McFarland HF, et al. (1986) Anti-beta-endorphin immunoglobulin G in Humans. Proc Nat Acad Sci 83: 8793–4

    Article  Google Scholar 

  37. Roy BF, Rose JW, Sunderland T, et al. (1988) Antisomatostatin IgG in major depressive disorder: a preliminary study with implications for an autoimmune mechanism of depression. Arch Gen Psychiatry 45: 924–8

    Article  PubMed  CAS  Google Scholar 

  38. Maes M, Delange J, Ranjan R, et al. (1997) Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 66: 1–11

    Article  PubMed  CAS  Google Scholar 

  39. Nunes SO, Reiche EM, Morimoto HK, et al. (2002) Immune and hormonal activity in adults suffering from depression. Braz J Med Biol Res 35: 581–7

    Article  PubMed  CAS  Google Scholar 

  40. Song C, Dinan T, Leonard BE (1994) Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 30: 283–8

    Article  PubMed  CAS  Google Scholar 

  41. Legros S, Mendlewicz J, Wybran J (1985) Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders. Eur Arch Psychiatry Neurol Sci 235: 9–11

    Article  PubMed  CAS  Google Scholar 

  42. Garcia FD, Coquerel Q, do Rego JC, et al. (2012) Anti-neuropeptide Y plasma immunoglobulins in relation to mood and appetite in depressive disorder. Psychoneuroendocrinology 37: 1457–67

    Article  PubMed  CAS  Google Scholar 

  43. Garcia FD, Coquerel Q, Kiive E, et al. (2011) Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. Prog Neuropsychopharmacol Biol Psychiatry 35: 118–25

    Article  PubMed  CAS  Google Scholar 

  44. Joyce PR, Hawes CR, Mulder RT, et al. (1992) Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 32: 1035–41

    Article  PubMed  CAS  Google Scholar 

  45. Van Hunsel F, Wauters A, Vandoolaeghe E, et al. (1996) Lower total serum protein, albumin, and beta-and gamma-globulin in major and treatmentresistant depression: effects of antidepressant treatments. Psychiatry Res 65: 159–69

    Article  PubMed  Google Scholar 

  46. Bauer J, Hohagen F, Gimmel E, et al. (1995) Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol Psychiatry 38: 611–21

    Article  PubMed  CAS  Google Scholar 

  47. Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113: 472–86

    Article  PubMed  CAS  Google Scholar 

  48. 52 Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29: 201–17

    Article  PubMed  CAS  Google Scholar 

  49. Fetissov SO, Hallman J, Nilsson I, et al. (2006) Aggressive behavior linked to corticotropin-reactive autoantibodies. Biol Psychiatry 60: 799–802

    Article  PubMed  CAS  Google Scholar 

  50. Karaiskos D, Mavragani CP, Sinno MH, et al. (2010) Psychopathological and personality features in primary Sjogren’s syndrome—associations with autoantibodies to neuropeptides. Rheumatology 49(9): 1762–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Duarte Garcia .

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Garcia, F.D. (2014). Apport de la neuro-immunologie en psychiatrie. In: Apport des neurosciences à la psychiatrie clinique. Springer, Paris. https://doi.org/10.1007/978-2-8178-0505-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0505-4_5

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0504-7

  • Online ISBN: 978-2-8178-0505-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics